Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020064966 - PREDICTIVE AND PROGNOSTIC METHODS IN BREAST CANCER

Publication Number WO/2020/064966
Publication Date 02.04.2020
International Application No. PCT/EP2019/076109
International Filing Date 26.09.2019
IPC
C12Q 1/6886 2018.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
6886for cancer
CPC
C12Q 1/6886
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
6886for cancer
C12Q 2600/106
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
C12Q 2600/158
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
158Expression markers
Applicants
  • BIONTECH DIAGNOSTICS GMBH [DE]/[DE]
  • STRATIFYER MOLECULAR PATHOLOGY GMBH [DE]/[DE]
Inventors
  • LAIBLE, Mark
  • OED, Michael
  • WIRTZ, Ralph
Agents
  • MÜLLER, Christian
Priority Data
PCT/EP2018/07627927.09.2018EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PREDICTIVE AND PROGNOSTIC METHODS IN BREAST CANCER
(FR) MÉTHODES PRÉDICTIVES ET PRONOSTIQUES DANS LE CANCER DU SEIN
Abstract
(EN)
The present invention relates to methods of predicting the probability of pathological complete response (pCR) of a breast cancer patient upon neo-adjuvant chemotherapy, to methods for selecting a breast cancer treatment, to methods of treatment of breast cancer, and to methods of prognosis of breast cancer upon breast cancer treatment.
(FR)
La présente invention concerne des procédés de prédiction de la probabilité de réponse complète pathologique (pCR) d'un patient atteint d'un cancer du sein lors d'une chimiothérapie néo-adjuvante, des procédés de sélection d'un traitement du cancer du sein, des procédés de traitement du cancer du sein, et des procédés de pronostic du cancer du sein lors du traitement du cancer du sein.
Latest bibliographic data on file with the International Bureau